申请人:CS Pharmatech Limited
公开号:US20200131176A1
公开(公告)日:2020-04-30
The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R
2
, R
3
, R
10
, E
1
, E
2
, E
3
, Y, and Z are as defined herein.